Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
September 11, 2007

Debiopharm Receives cGMP Certification for QC of Drug Products

  • Debiopharm achieved cGMP certification from Swissmedic for the chemical, physical, and biochemical quality control work conducted at its laboratory in Gland, Switzerland. Debiopharm now has the alternative to handle its analytical development, formulation, and quality control activities in-house when necessary, according to Kamel Besseghir, CEO.

    Debiopharm also has a cGMP development and production facility in Martigny, Switzerland, which has been inspected by the FDA and Swissmedic. The company reports that it can produce pilot batches of cGMP drug products for feasibility studies, clinical trial supplies, and commercial-scale manufacturing.

  • Finally! A cure for the Biotech News Blues.

  • Join 110,000 colleagues who rely on GEN Highlights for breaking news and exclusive articles shaping today’s life science tools and technologies.

  • Oops! Please type your email in the following format: yourname@example.com An error has occurred. Please contact Customer Service at contactGEN@genengnews.com
  • You’re all set! Thank you for subscribing to GEN Highlights.